Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 281
1.
Transpl Int ; 37: 12439, 2024.
Article En | MEDLINE | ID: mdl-38751770

Due to its intrinsic complexity and the principle of collective solidarity that governs it, solid organ transplantation (SOT) seems to have been spared from the increase in litigation related to medical activity. Litigation relating to solid organ transplantation that took place in the 29 units of the Assistance Publique-Hôpitaux de Paris and was the subject of a judicial decision between 2015 and 2022 was studied. A total of 52 cases of SOT were recorded, all in adults, representing 1.1% of all cases and increasing from 0.71% to 1.5% over 7 years. The organs transplanted were 25 kidneys (48%), 19 livers (37%), 5 hearts (9%) and 3 lungs (6%). For kidney transplants, 11 complaints (44%) were related to living donor procedures and 6 to donors. The main causes of complaints were early post-operative complications in 31 cases (60%) and late complications in 13 cases (25%). The verdicts were in favour of the institution in 41 cases (79%). Solid organ transplants are increasingly the subject of litigation. Although the medical institution was not held liable in almost 80% of cases, this study makes a strong case for patients, living donors and their relatives to be better informed about SOT.


Hospitals, University , Organ Transplantation , Humans , Organ Transplantation/legislation & jurisprudence , Hospitals, University/legislation & jurisprudence , Adult , Male , Female , Postoperative Complications , Living Donors/legislation & jurisprudence , Middle Aged , Liver Transplantation/legislation & jurisprudence , Liver Transplantation/adverse effects , Kidney Transplantation/legislation & jurisprudence , Europe , Lung Transplantation/legislation & jurisprudence
2.
Exp Clin Transplant ; 22(Suppl 4): 28-32, 2024 Apr.
Article En | MEDLINE | ID: mdl-38775694

The first living donor kidney transplant in Syria was performed 44 years ago; by the end of 2022, 6265 renal transplants had been performed in Syria. Kidney, bone marrow, cornea, and stem cells are the only organs or tissues that can be transplanted in Syria. Although 3 heart transplants from deceased donors were performed in the late 1980s, cardiac transplant activities have since discontinued. In 2003, national Syrian legislation was enacted authorizing the use of organs from living unrelated and deceased donors. This important law was preceded by another big stride: the acceptance by the higher Islamic religious authorities in Syria in 2001 of the principle of procurement of organs from deceased donors, provided that consent is given by a first- or second-degree relative. After the law was enacted, kidney transplant rates increased from 7 per million population in 2002 to 17 per million population in 2007. Kidney transplants performed abroad for Syrian patients declined from 25% in 2002 to <2% in 2007. Rates plateaued through 2010, before the political crisis started in 2011. Forty-four years after the first successful kidney transplant in Syria, patients needing an organ transplant rely on living donors only. Moreover, 20 years after the law authorizing use of organs from deceased donors, a program is still not in place in Syria. The war, limited resources, and lack of public awareness about the importance of organ donation and transplant appear to be factors inhibiting initiation of a deceased donor program in Syria. A concerted and ongoing education campaign is needed to increase awareness of organ donation, change negative public attitudes, and gain societal acceptance. Every effort must be made to initiate a deceased donor program to lessen the burden on living donors and to enable national self-sufficiency in organs for transplant.


Living Donors , Organ Transplantation , Tissue Donors , Tissue and Organ Procurement , Humans , Syria , Tissue and Organ Procurement/legislation & jurisprudence , Tissue and Organ Procurement/trends , Organ Transplantation/legislation & jurisprudence , Organ Transplantation/trends , Living Donors/supply & distribution , Living Donors/legislation & jurisprudence , Tissue Donors/supply & distribution , Tissue Donors/legislation & jurisprudence , Religion and Medicine , Kidney Transplantation/legislation & jurisprudence , Islam , Time Factors , Health Policy/legislation & jurisprudence , Government Regulation
3.
J Int Bioethique Ethique Sci ; 34(2): 133-142, 2023.
Article Fr | MEDLINE | ID: mdl-37684201

The new French bioethical legislation does not introduce any major changes in the area of organ transplantation. It does, however, facilitate the implementation of cross-over donation programs by increasing the number of living donor/recipient pairs eligible to participate in the program. By setting the number of pairs at six, the law is likely to allow this promising transplant program to take off. In order to mitigate the risk of a donor withdrawing and to facilitate the matching, the legislator has chosen to integrate a deceased donor organ to initiate the cross-donation program. This pragmatic choice reflects the hybrid regime of cross-over donation, since the legislator, while reaffirming the attachment to the principles of living donation, borrows from the logic of post-mortem donation.


Living Donors , Humans , Living Donors/ethics , Living Donors/legislation & jurisprudence
5.
Ned Tijdschr Geneeskd ; 1642020 06 18.
Article Nl | MEDLINE | ID: mdl-32749821

There is a shortage of donor livers from deceased persons, which means there is a relatively high mortality rate among patients on the national liver-transplant waiting list in the Netherlands. This justifies expanding the current programme for liver transplants from living donors. The new law on donor organs law came into effect on 1 July 2020. The expectation is that this will lead to a greater supply of post-mortem donor livers. New methods for organ preservation could also lead to an increase in the number of available donor livers. An increase in the supply of donor livers could lead to changes in donor policy. These changes should take into consideration that a liver transplant from a living donor can take place earlier in the course of the disease and that the quality of the donor liver is better, which means that outcomes for the recipient are also better.


Liver Transplantation/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence , Waiting Lists , Humans , Living Donors/supply & distribution , Netherlands , Tissue Donors/legislation & jurisprudence
6.
Rev. esp. med. legal ; 45(4): 147-154, oct.-dic. 2019. ilus, graf
Article Es | IBECS | ID: ibc-188619

La donación corporal es la base de los programas de trasplantes, cuya regulación se fundamenta en los derechos del donante y receptor. Sin embargo, si su objetivo no es asistencial, la normativa difiere tanto en vivos como en fallecidos. Las llamadas «técnicas de imagen» permiten obtener ficheros digitales con el cuerpo virtual del paciente, lo que brinda una nueva posibilidad: la donación corporal virtual, no regulada en España y tampoco ajustada a la normativa del resto de las donaciones. Presentamos un programa de donación corporal, analizando sus características, aspectos médico-legales, clínicos, de organización y funcionamiento. Contar con un número ilimitado de especímenes virtuales impulsa una nueva forma de docencia e investigación. Tiene, además, ventajas para la formación de los profesionales en técnicas de autopsia virtual. Creemos que este programa, pionero en España, puede servir para extender iniciativas similares de utilidad ilimitada en docencia e investigación en ciencias forenses, morfológicas y afines


Body donation is in the basis of transplantation programs, founded on receptor and donor rights. Nevertheless, if the purpose is not directed to healthcare, the regulation is different both in live or deceased individuals. "Imaging techniques" generates digital files containing the «virtual body» of the patient, raising a new possibility: virtual body donation, which is not regulated in Spain and would not be compliant with legal requirements for other ways of donation. A pioneer program for virtual body donation is presented, analysing its characteristics, medico-legal issues, organisation and functioning. Having an unlimited number of virtual specimens (normal and pathological) could support a new way for teaching and research. These resources would also have the advantage of learning virtual biopsy (virtopsy). It is thought that these programs, pioneers in Spain, could be useful for introducing similar initiatives that would have unlimited applications in teaching and research both in forensic and morphological sciences


Humans , Tissue Donors/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Bioethical Issues , Virtual Reality , Informed Consent/legislation & jurisprudence , Informed Consent/standards
7.
Saudi J Kidney Dis Transpl ; 30(5): 1111-1117, 2019.
Article En | MEDLINE | ID: mdl-31696850

The prevalence of end-stage renal disease (ESRD) morbidity and mortality is mounting. Kidney transplantation offers a good means of survival and improves longevity of patients with ESRD. However, not everyone is fortunate to benefit from this lifesaving renal replacement therapy due to the lack of available kidneys, one of the many reasons. It eventually expands the number of patients on waiting list of kidney transplantation. At present, deceased and living-related kidney donor transplantation models are widely used, but with limited success to keep up with the pace of burgeoning ESRD. A debate over the legalization of unrelated living kidney donor transplantation has erupted lately. This short review articles focuses on issues surrounding kidney transplantation in Pakistan and draws an informed conclusion regarding pragmatic legalization of unrelated living kidney donor transplantation in exceptional circumstances. Finally, this article also offers a food for thought for countries facing analogous picture in the field of kidney transplantation.


Donor Selection/legislation & jurisprudence , Health Services Accessibility/legislation & jurisprudence , Kidney Failure, Chronic/surgery , Kidney Transplantation/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Policy Making , Unrelated Donors/legislation & jurisprudence , Government Regulation , Humans , Kidney Failure, Chronic/mortality , Living Donors/supply & distribution , Pakistan/epidemiology , Unrelated Donors/supply & distribution
8.
J Med Philos ; 44(4): 442-458, 2019 Jul 29.
Article En | MEDLINE | ID: mdl-31356660

Lethal organ donation is a hypothetical procedure in which vital organs are removed from living donors, resulting in their death. An important objection to lethal organ donation is that it would infringe the prohibition on doctors intentionally causing the death of patients. I present a series of arguments intended to undermine this objection. In a case of lethal organ donation, the donor's death is merely foreseen, and not intended.


Death , Living Donors/ethics , Terminally Ill , Tissue and Organ Procurement/ethics , Humans , Informed Consent , Intention , Living Donors/legislation & jurisprudence , Philosophy, Medical , Tissue and Organ Procurement/legislation & jurisprudence
10.
Chirurg ; 90(6): 496-500, 2019 Jun.
Article De | MEDLINE | ID: mdl-31069415

At the end of January 2019 the German Federal Court of Justice (Bundesgerichtshof, BGH) heard oral arguments and made a judgment in cases regarding living organ donors. The core verdicts concerned questions regarding the necessary information which has to be provided in order to properly inform the donor. This article outlines the main findings of the BGH because every transplantation surgeon has to be aware of them. In addition, this article focuses on the possibilities for hospitals to fulfill the legal requirement of the presence of an impartial doctor during the informed consent for a living organ donor.


Living Donors , Surgeons , Tissue and Organ Procurement , Humans , Informed Consent , Living Donors/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence
11.
J Med Philos ; 44(3): 314-334, 2019 May 18.
Article En | MEDLINE | ID: mdl-30950498

Several commentators have tried to ground legal prohibitions of kidney sales in some form of Kant's moral arguments against such sales. This paper reconsiders this approach to justifying laws and policies in light of Kant's approach to law in his political philosophy. The author argues that Kant's political philosophy requires that kidney sales be legally permitted, although contracts for such sales must remain unenforceable. The author further argues that Kant's approach to laws, such as those governing kidney distribution, was formed in part by considering and rejecting an assumption frequently employed in the bioethics literature, namely, that legal duties can be grounded directly in moral duties. The author explains some of Kant's reasons for rejecting this assumption and concludes that arguments pertaining to the legality of kidney sales developed on the basis of Kant's moral philosophy should no longer be considered tenable.


Kidney , Living Donors/ethics , Living Donors/legislation & jurisprudence , Remuneration , Bioethical Issues , Ethical Theory , Humans , Morals , Philosophy, Medical , Politics
12.
Exp Clin Transplant ; 17(Suppl 1): 1-5, 2019 01.
Article En | MEDLINE | ID: mdl-30777517

In Jordan, the history of organ transplantation started in 1972 with a kidney transplant from a deceased donor. At present, Jordan is in a good position with regard to organ transplantation among developing countries. It remains important to follow through with some decisions and enact laws that would increase the percentage of legal organ donations and transplant procedures. This has involved the expansion of relative degree donation. Until 2013, most relative degree donations involved 1st-degree and 2nd-degree relatives. The degree of genetical and legal relatives in living organ donation was then expanded to allow 4th- and 5th-degree relatives. This expansion to a 5th-degree relative came about when it was realized that the percentage of organ transplants in 2nd-degree relatives was high. Therefore, the idea of organ donation in these degrees may be beneficial, as it can lead to significantly higher numbers of organ donations.


Family , Living Donors/supply & distribution , Organ Transplantation/methods , Pedigree , Health Policy , History, 20th Century , History, 21st Century , Humans , Islam , Jordan , Living Donors/history , Living Donors/legislation & jurisprudence , Organ Transplantation/history , Organ Transplantation/legislation & jurisprudence , Policy Making , Religion and Medicine
15.
Saudi J Kidney Dis Transpl ; 29(5): 1181-1187, 2018.
Article En | MEDLINE | ID: mdl-30381516

Kidney transplantation is the gold standard for end-stage renal disease. All over the world there are several challenges preventing sufficient organ donation to meet the growing needs of patients on the waiting list. One major challenge which is common to most countries is the shortage of organs from willing living donors. Many countries, especially, the developed countries, have devised several models of expanding their donor pools to meet the growing needs of patients on the waiting list. Nigeria, a developing country has very low kidney transplantation rate even though some progress have been made in making the procedure feasible in about a dozen hospitals in Nigeria. One very major challenge has been the shortage of donor organ supply. This paper intends to proffer suggestions on how to expand the organ donor pool in Nigeria.


Kidney Failure, Chronic/surgery , Kidney Transplantation/methods , Living Donors/supply & distribution , Tissue and Organ Procurement , Delivery of Health Care, Integrated , Health Education/methods , Health Knowledge, Attitudes, Practice , Health Policy , Humans , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/epidemiology , Kidney Transplantation/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Nigeria/epidemiology , Policy Making , Registries , Tissue and Organ Procurement/legislation & jurisprudence , Waiting Lists
16.
Am J Law Med ; 44(1): 67-118, 2018 Mar.
Article En | MEDLINE | ID: mdl-29764323

Live kidney donation involves a delicate balance between saving the most lives possible and maintaining a transplant system that is fair to the many thousands of patients on the transplant waiting list. Federal law and regulations require that kidney allocation be equitable, but the pressure to save patients subject to ever-lengthening waiting times for a transplant has been swinging the balance toward optimizing utility at the expense of justice. This article traces the progression of innovations created to make optimum use of a patient's own live donors. It starts with the simplest - direct donation by family members - and ends with voucher donations, a very recent and unique innovation because the donor can donate 20 or more years before the intended recipient is expected to need a kidney. In return for the donation, the intended recipient receives a voucher that can be redeemed for a live kidney when it is needed. Other innovations that are discussed include kidney exchanges and list paired donation, which are used to facilitate donor swaps when donor/recipient pairs have incompatible blood types. The discussion of each new innovation shows how the equity issues build on each other and how, with each new innovation, it becomes progressively harder to find an acceptable balance between utility and justice. The article culminates with an analysis of two recent allocation methods that have the potential to save many additional lives, but also affirmatively harm some patients on the deceased donor waiting list by increasing their waiting time for a life-saving kidney. The article concludes that saving additional lives does not justify harming patients on the waiting list unless that harm can be minimized. It also proposes solutions to minimize the harm so these new innovations can equitably perform their intended function of stimulating additional transplants and extending the lives of many transplant patients.


Kidney Transplantation/legislation & jurisprudence , Liver Transplantation/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Tissue and Organ Procurement/legislation & jurisprudence , Directed Tissue Donation/ethics , Directed Tissue Donation/legislation & jurisprudence , Donor Selection/ethics , Humans , Kidney Transplantation/ethics , Liver Transplantation/ethics , Living Donors/ethics , Tissue and Organ Procurement/ethics , Waiting Lists
17.
Transplantation ; 102(5): 803-808, 2018 05.
Article En | MEDLINE | ID: mdl-29708521

Due to the widening gap between supply and demand, patients who need a liver transplant due to metabolic disease may be asked to serve as domino liver donors-to have their native liver transplanted into another candidate. We here analyze the ethical problems surrounding informed consent for the implant and explant procedures in transplant candidates who will serve as domino donors, using the case of a child with maple syrup urine disease. We discuss the need for 2 distinct consent processes separated in time to ensure that potential domino donors (or their surrogates) give a truly voluntary consent. We propose a Domino Donor Advocate-based on the concept of the independent living donor advocate to help the patient and/or his or her surrogates consider the risks, benefits and alternatives. Finally, we evaluate the Organ Procurement and Transplantation Network policy regarding "therapeutic organ donation" and propose several modifications to ensure that the decision by the potential domino donor (and/or his or her surrogate) is voluntary and informed.


Ethical Analysis , Informed Consent/ethics , Informed Consent/legislation & jurisprudence , Liver Transplantation/ethics , Liver Transplantation/legislation & jurisprudence , Living Donors/ethics , Living Donors/legislation & jurisprudence , Maple Syrup Urine Disease/surgery , Policy Making , Clinical Decision-Making/ethics , Humans , Liver Transplantation/methods , Living Donors/psychology , Living Donors/supply & distribution , Maple Syrup Urine Disease/diagnosis , Maple Syrup Urine Disease/genetics , Maple Syrup Urine Disease/metabolism , Patient Selection/ethics , Risk Assessment , Risk Factors , Volition
18.
Isr J Health Policy Res ; 7(1): 11, 2018 03 16.
Article En | MEDLINE | ID: mdl-29544525

In 2008, responding to a widening gap between need and availability of transplant organs, Israel's Ministry of Health adopted a program of incentivized cadaveric organ donation. The Organ Transplant Law rewards individuals with prioritized access to organs on the condition that they participate in procurement efforts. Priority is awarded in the form of additional points allocated to the individual's organ recipient profile. Although Israel has experienced moderate gains in the years since the law's implementation, these have not been sufficient to satisfy the demand. Furthermore, the law faces logistical and ethical challenges. These challenges could potentially be resolved by shifting the organ procurement default to routine retrieval rather than the current default of presumed refusal to organ retrieval.This paper examines philosophical and practical challenges to the priority points policy and weighs whether Israel should consider an alternative policy of routine retrieval of transplant organs with the option to opt out of the donor pool.


Living Donors/ethics , Tissue and Organ Procurement/ethics , Transplants/supply & distribution , Health Policy , Humans , Living Donors/legislation & jurisprudence , Motivation , Tissue and Organ Procurement/legislation & jurisprudence
20.
J Med Ethics ; 44(5): 310-313, 2018 May.
Article En | MEDLINE | ID: mdl-29102919

We do not always benefit from the expansion of our choice sets. This is because some options change the context in which we must make decisions in ways that render us worse off than we would have been otherwise. One promising argument against paid living kidney donation holds that having the option of selling a 'spare' kidney would impact people facing financial pressures in precisely this way. I defend this argument from two related criticisms: first, that having the option to sell one's kidney would only be harmful if one is pressured or coerced to take this specific course of action; and second, that such forms of pressure are unlikely to feature in a legal market.


Kidney Transplantation/economics , Living Donors/ethics , Tissue and Organ Harvesting/economics , Tissue and Organ Procurement/economics , Coercion , Commerce , Ethics, Medical , Health Care Sector/economics , Health Care Sector/ethics , Humans , Kidney Transplantation/ethics , Kidney Transplantation/legislation & jurisprudence , Living Donors/legislation & jurisprudence , Morals , Poverty , Tissue and Organ Harvesting/ethics , Tissue and Organ Harvesting/legislation & jurisprudence , Tissue and Organ Procurement/ethics , Tissue and Organ Procurement/legislation & jurisprudence
...